Pharmaceutical industry
The latest news relating to the pharmaceuticals industry, including regulation, litigation, business news and relevant industrial and academic research, from the Royal Society of Chemistry's magazine, Chemistry World
-
Opinion
Improving women’s health research will benefit everyone
Fixing the inequality is morally just, and economically sound
-
Opinion
Women are not just another confounding factor in drug development
Ignoring physiological differences between the sexes is indefensible
-
Business
Trade deals stave off Trump’s tariffs temporarily
Initial agreements with China and UK have paused trade war, but uncertainty reigns
-
Opinion
Rebuilding pharma supply chains
Multinationals are promising huge US investments, but it’s not all because of Trump’s policies
-
Opinion
In search of truth and rules
To codify and predict ever more complex phenomena is one of science’s great drivers
-
Business
Merck KGaA to buy cancer specialist SpringWorks
$3.9 billion deal boosts Merck’s pipeline as it faces patent expiries
-
Business
Gilead settles US HIV drug kickback lawsuit
Firm will pay $202 million to federal and state governments
-
Whitepaper
Optimise drug discovery: predicting transporter-mediated drug interactions
Learn how in vitro models, biomarkers and modelling can improve prediction of drug interactions and toxicity – reducing false positives and unnecessary clinical studies
-
Business
Free energy methods and digital transformation of drug discovery
Synergistic application of AI-based generative chemistry and free energy methods streamlines molecule discovery and optimisation
-
Opinion
Polymorphs matter – especially when they might disappear
Disappearing polymorphs offer a fascinating example of the dark arts of crystallisation
-
News
Fears grow over the future of mRNA vaccine research in the US
Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad
-
Business
Acceptable levels of (epi)genetic engineering
Amplifying or silencing genes may be preferable to permanently changing genetic code
-
Opinion
The value of good software extends beyond its cost
Whether third-party or built in-house, thoughtful design and implementation can improve workflows and make science more inclusive
-
Business
Government reduces UK Reach fees by ‘£40 million’
Registration fees for most chemicals reduced, but uncertainty remains over safety data requirements
-
Business
Epigenetic editors enter clinical trials
New wave of precision medicines amplify or silence genes, without altering genetic code
-
Opinion
Trump’s tariff stand-off
Piling cost and complexity to stretched global supply chains will hit industries hard
-
Business
Trump’s new tariffs threaten the chemicals sector
Broad and high tariffs could mean severe job losses and supply chain disruption for chemistry-using industries
-
Business
J&J’s third talc bankruptcy settlement attempt denied
Company says it will return to courts to fight talc cancer claims
-
Business
US regulatory chief’s resignation raises alarms in biotech industry
FDA vaccines and biologicals centre director, Peter Marks, clashed with health secretary Robert F Kennedy Jr
-
Opinion
Welcome to the MegaPharm target selection and project resourcing meeting
Overheard recently in a seminar room near you…